Oriola-KD Corporation will publish the interim report 1 January - 30 June 2015 on Friday, 17 July 2015 at 8.30 a.m.

Oriola-KD's interim report Q2 2015 (Stock Exchange Release)


A meeting for investors, analysts and the press is arranged on the same day starting at 10.00 a.m. at Hotel Scandic Simonkenttä. A teleconference on the financial information is starting at 2.00 p.m.


Invitation and registration


Follow the teleconference via live audiocast

Related sites


Media follow-up

17 juli 2015
17 juli 2015

Finland: Oriola-KD’s interim report meets analysts’ targets

Pharmaceutical wholesaler Oriola-KD has published its April – June and January – June 2015 interim report. The company reported its 2015 second quarter operating profit to be EUR 14.9 million (14.2), which had been accordingly forecasted by FactSet. The turnover from Q2 2015 amounted to EUR 417.1 million.

Seven analysts estimated the company to make an operating profit between EUR 14 and 15.3 million. The company was also expected to book net sales worth EUR 414 million.

Oriola-KD now expects its full-year net sales to remain at the 2014 level. The 2014 net sales from continuing operations amounted to EUR 1,612.3 million and operating profit excluding non-recurring items was EUR 59.1 million.

Intelligence reporting by M-brain

Original article on Arvopaperi in Finnish language

Similar article on Taloussanomat in Finnish language

Similar article on Kauppalehti in Finnish language

Similar article on Uutisaalto in Finnish language
28 maj 2015
28 maj 2015

Sweden: Pharmacies and logistics - competitive advantage for Kronans Apotek

Kronans Apotek hopes that operating pharmacies as well as logistics business gives the company a competitive advantage when entering the market of supplying medicines to the county councils’ health care services.

The pharmacist Christian Vallentin who manages the business area Healthcare Customers & Companies at Kronans Apotek says the company decided in favour of this investment last year.

“This is a very interesting market, the borders between the medicines for inpatient and outpatient treatment are fading. Through operating both within outpatient and inpatient care we believe we have the best preconditions to be competitive.” The pharmacies and sister company in logistics make Kronans Apotek a strong partner in health care sector, and the company plans to be active in the upcoming procurements, promises Christian Vallentin.

Intelligence reporting by M-brain

Original article on Svensk Farmaci in Swedish language

Read more